Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis: A phase 2b randomized study

Atopic dermatitis (AD) is associated with a substantial burden on quality of life (QoL). To evaluate the effects of tralokinumab on health-related QoL in patients with moderate-to-severe AD using patient-reported outcomes. This was a phase 2b, randomized, double-blind, placebo-controlled, dose-rangi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of allergy, asthma, & immunology asthma, & immunology, 2021-05, Vol.126 (5), p.576-583.e4
Hauptverfasser:	Silverberg, Jonathan I, Guttman-Yassky, Emma, Gooderham, Melinda, Worm, Margitta, Rippon, Stephanie, O'Quinn, Sean, van der Merwe, René, Kragh, Nana, Kurbasic, Azra, Wollenberg, Andreas
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!